Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Karolina Okla, Iwona Wertel, Anna Wawruszak, Marcin Bobiński & Jan Kotarski. (2018) Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells – is a new era coming?. Critical Reviews in Clinical Laboratory Sciences 55:6, pages 376-407.
Read now
Read now
Himanshu Kumar & Adrian Bot. (2016) In This Issue: Cellular and Molecular Mechanisms Orchestrating the Innate Immunity During Infectious and Non-infectious Disease. International Reviews of Immunology 35:5, pages 369-371.
Read now
Read now
Articles from other publishers (20)
Alicja Rajtak, Arkadiusz Czerwonka, Michael Pitter, Jan Kotarski & Karolina Okła. (2023) Clinical Relevance of Mortalin in Ovarian Cancer Patients. Cells 12:5, pages 701.
Crossref
Crossref
Yusha Wang, Lei Zhang, Yun Bai, Li Wang & Xuelei Ma. (2022) Therapeutic implications of the tumor microenvironment in ovarian cancer patients receiving PD-1/PD-L1 therapy. Frontiers in Immunology 13.
Crossref
Crossref
Yaqian Zhao, Jiani Yang, Nan Zhang, Yue Jin, Minghai Zhang, Shanshan Cheng & Yu Wang. (2022) Integrative analysis of the expression and prognosis for CENPs in ovarian cancer. Genomics 114:5, pages 110445.
Crossref
Crossref
Fabian Flores-Borja & Paul Blair. (2022) Mechanisms of induction of regulatory B cells in the tumour microenvironment and their contribution to immunosuppression and pro-tumour responses. Clinical and Experimental Immunology 209:1, pages 33-45.
Crossref
Crossref
Ling Li, Dian Chen, Xiaolin Luo, Zhengkun Wang, Hanjie Yu, Weicheng Gao & Weiqiang Zhong. (2022) Identification of CD8+ T Cell Related Biomarkers in Ovarian Cancer. Frontiers in Genetics 13.
Crossref
Crossref
Kazuhiko Matsuo, Osamu Yoshie & Takashi Nakayama. (2021) Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity. Cancers 13:23, pages 6132.
Crossref
Crossref
Khadijeh Koushki, Maryam Salemi, Seyed Mohammad Miri, Yaser Arjeini, Mohsen Keshavarz & Amir Ghaemi. (2021) Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19. Biomedicine & Pharmacotherapy 144, pages 112346.
Crossref
Crossref
Maureen L. Drakes & Patrick J. Stiff. 2021. Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies. Ovarian Cancer: Molecular & Diagnostic Imaging and Treatment Strategies
33
54
.
Karolina Okła, Alicja Rajtak, Arkadiusz Czerwonka, Marcin Bobiński, Anna Wawruszak, Rafał Tarkowski, Wiesława Bednarek, Justyna Szumiło & Jan Kotarski. (2020) Accumulation of blood-circulating PD-L1-expressing M-MDSCs and monocytes/macrophages in pretreatment ovarian cancer patients is associated with soluble PD-L1. Journal of Translational Medicine 18:1.
Crossref
Crossref
Maureen L. Drakes, Cheryl M. Czerlanis & Patrick J. Stiff. (2020) Immune Checkpoint Blockade in Gynecologic Cancers: State of Affairs. Cancers 12:11, pages 3301.
Crossref
Crossref
Diego Salas-Benito, Enric Vercher, Enrique Conde, Javier Glez-Vaz, Ibon Tamayo & Sandra Hervas-Stubbs. (2020) Inflammation and immunity in ovarian cancer. European Journal of Cancer Supplements 15, pages 56-66.
Crossref
Crossref
V. Heredia-Soto, J.A. López-Guerrero, A. Redondo & M. Mendiola. (2020) The hallmarks of ovarian cancer: Focus on angiogenesis and micro-environment and new models for their characterisation. European Journal of Cancer Supplements 15, pages 49-55.
Crossref
Crossref
Denisa Baci, Annalisa Bosi, Matteo Gallazzi, Manuela Rizzi, Douglas M. Noonan, Alessandro Poggi, Antonino Bruno & Lorenzo Mortara. (2020) The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors. International Journal of Molecular Sciences 21:9, pages 3125.
Crossref
Crossref
Xiaojing Ma. (2020) The omentum, a niche for premetastatic ovarian cancer. Journal of Experimental Medicine 217:4.
Crossref
Crossref
Nuzhat Ahmed, Elif Kadife, Ali Raza, Mary Short, Paul T. Jubinsky & George Kannourakis. (2020) Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods. Cells 9:3, pages 719.
Crossref
Crossref
Karolina Okła, Arkadiusz Czerwonka, Anna Wawruszak, Marcin Bobiński, Monika Bilska, Rafał Tarkowski, Wiesława Bednarek, Iwona Wertel & Jan Kotarski. (2019) Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer. Frontiers in Immunology 10.
Crossref
Crossref
Karolina Okła, Justyna Surówka, Karolina Frąszczak, Arkadiusz Czerwonka, Katarzyna Kaławaj, Anna Wawruszak, Jan Kotarski & Iwona Wertel. (2018) Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients. Tumor Biology 40:10, pages 101042831880493.
Crossref
Crossref
Curtis McCloskey, Galaxia Rodriguez, Kristianne Galpin & Barbara Vanderhyden. (2018) Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics. Cancers 10:8, pages 244.
Crossref
Crossref
Galaxia Rodriguez, Kristianne Galpin, Curtis McCloskey & Barbara Vanderhyden. (2018) The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy. Cancers 10:8, pages 242.
Crossref
Crossref
Alba Rodriguez-Garcia, Nicholas G. Minutolo, John M. Robinson & Daniel J. Powell. (2017) T-cell target antigens across major gynecologic cancers. Gynecologic Oncology 145:3, pages 426-435.
Crossref
Crossref